2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common Stock Value | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | NA | NA | NA | |
Weighted Average Number Of Diluted Shares Outstanding | 32.71 | NA | 32.35 | 32.20 | 31.97 | NA | 31.61 | 31.41 | 31.21 | NA | 27.71 | 27.34 | 27.29 | NA | NA | 5.61 | NA | |
Weighted Average Number Of Shares Outstanding Basic | 32.71 | NA | 32.35 | 32.20 | 31.97 | NA | 31.61 | 31.41 | 31.21 | NA | 27.71 | 27.34 | 27.29 | NA | 5.00 | 4.99 | 4.99 | |
Earnings Per Share Basic | -0.33 | -0.23 | -0.22 | -0.29 | -0.39 | -0.31 | -0.20 | -0.26 | -0.30 | -0.11 | -0.19 | -0.27 | -0.22 | -1.82 | -0.35 | 0.11 | -0.60 | |
Earnings Per Share Diluted | -0.33 | -0.23 | -0.22 | -0.29 | -0.39 | -0.31 | -0.20 | -0.26 | -0.30 | -0.11 | -0.19 | -0.27 | -0.22 | -1.82 | -0.34 | 0.10 | -0.60 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue From Contract With Customer Excluding Assessed Tax | 9.99 | 14.35 | 14.30 | 12.09 | 9.49 | 11.64 | 15.80 | 11.11 | 8.31 | 15.84 | 12.54 | 8.28 | 5.54 | 5.72 | 6.05 | 11.13 | 4.00 | |
Revenues | 9.99 | 14.35 | 14.30 | 12.09 | 9.49 | 11.64 | 15.80 | 11.11 | 8.31 | 15.84 | 12.54 | 8.28 | 5.54 | 5.72 | 6.05 | 11.13 | 4.00 | |
Cost Of Revenue | 4.99 | 7.08 | 6.43 | 6.30 | 5.10 | 5.72 | 6.46 | 4.47 | 4.18 | 6.71 | 5.73 | 3.90 | 2.63 | 3.14 | 2.21 | 4.72 | 1.90 | |
Gross Profit | 5.00 | 7.28 | 7.87 | 5.79 | 4.38 | 5.92 | 9.34 | 6.63 | 4.13 | 9.13 | 6.81 | 4.38 | 2.91 | 2.58 | 3.84 | 6.41 | 2.10 | |
Operating Expenses | 17.69 | 16.99 | 16.96 | 16.73 | 17.40 | 16.26 | 16.49 | 15.00 | 13.65 | 12.66 | 12.09 | 11.83 | 8.72 | 6.46 | 5.13 | 4.28 | 4.86 | |
Research And Development Expense | 5.79 | 5.44 | 5.54 | 5.53 | 5.40 | 4.66 | 4.67 | 4.29 | 3.90 | 3.75 | 3.30 | 3.06 | 2.96 | 2.28 | 1.95 | 1.85 | 2.16 | |
Selling General And Administrative Expense | 11.90 | 11.54 | 11.42 | 11.21 | 12.00 | 11.60 | 11.83 | 10.71 | 9.74 | 8.92 | 8.79 | 8.78 | 5.75 | 4.18 | 3.18 | 2.44 | 2.71 | |
Operating Income Loss | -12.69 | -9.71 | -9.09 | -10.94 | -13.02 | -10.34 | -7.15 | -8.37 | -9.52 | -3.53 | -5.28 | -7.46 | -5.81 | -3.89 | -1.29 | 2.13 | -2.76 | |
Interest Expense | NA | 0.00 | -0.35 | 0.00 | 0.55 | 0.06 | 0.03 | 0.01 | 0.02 | 0.04 | 0.03 | 0.04 | 0.38 | 0.24 | 0.24 | 0.25 | 0.24 | |
Gains Losses On Extinguishment Of Debt | NA | 0.01 | 0.32 | 0.00 | -0.52 | -0.04 | -0.00 | -0.00 | -0.00 | -0.01 | 0.00 | -0.00 | -0.17 | -0.01 | -0.02 | -0.02 | -0.02 | |
Allocated Share Based Compensation Expense | 2.64 | 2.34 | 2.70 | 2.58 | 2.17 | 2.00 | 2.02 | 1.89 | 1.29 | 0.87 | 0.81 | 0.48 | 0.34 | 0.31 | 0.08 | 0.07 | 0.07 | |
Income Tax Expense Benefit | -0.07 | -0.00 | -0.09 | -0.07 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Profit Loss | -10.92 | -7.43 | -7.09 | -9.35 | -12.53 | -9.79 | -6.26 | -8.10 | -9.41 | -3.46 | -5.18 | -7.42 | -6.09 | -10.23 | -1.72 | 2.10 | -2.97 | |
Net Income Loss | -10.92 | -7.43 | -7.09 | -9.35 | -12.53 | -9.79 | -6.26 | -8.10 | -9.41 | -3.46 | -5.18 | -7.42 | -6.09 | 15.39 | -1.72 | 2.10 | -2.97 | |
Comprehensive Income Net Of Tax | -11.30 | -7.05 | -7.25 | -9.29 | -12.24 | -8.38 | -6.87 | -8.10 | -9.41 | -3.46 | -5.18 | NA | NA | NA | NA | NA | NA |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | 189.79 | 202.98 | 208.47 | 210.83 | 218.41 | 242.59 | 249.28 | 247.00 | 251.23 | 260.91 | 166.30 | 166.48 | 171.75 | 178.83 | NA | NA | NA | |
Liabilities | 32.90 | 37.49 | 38.55 | 36.37 | 37.80 | 51.99 | 52.78 | 45.88 | 44.42 | 46.30 | 43.53 | 39.82 | 38.44 | 39.79 | NA | NA | NA | |
Liabilities And Stockholders Equity | 189.79 | 202.98 | 208.47 | 210.83 | 218.41 | 242.59 | 249.28 | 247.00 | 251.23 | 260.91 | 166.30 | 166.48 | 171.75 | 178.83 | NA | NA | NA | |
Stockholders Equity | 156.89 | 165.49 | 169.93 | 174.46 | 180.61 | 190.60 | 196.50 | 201.12 | 206.80 | 214.60 | 122.78 | 126.67 | 133.31 | 139.04 | -65.61 | -63.95 | -66.09 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | 161.87 | 173.79 | 179.83 | 181.08 | 187.94 | 215.63 | 223.88 | 238.68 | 242.98 | 252.89 | 157.49 | 157.19 | 162.96 | 170.97 | NA | NA | NA | |
Cash And Cash Equivalents At Carrying Value | 104.60 | 121.04 | 118.21 | 133.00 | 161.21 | 188.42 | 193.70 | 212.99 | 223.12 | 224.07 | 138.81 | 141.31 | 148.96 | 159.23 | 19.71 | 11.34 | 14.66 | |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 104.77 | 121.21 | 118.38 | 133.17 | 161.38 | 188.59 | 193.87 | 213.16 | 223.18 | 224.13 | 138.88 | 141.37 | 149.02 | 159.23 | 19.71 | 11.34 | 14.66 | |
Marketable Securities Current | 29.60 | 24.64 | 29.68 | 19.69 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Accounts Receivable Net Current | 7.49 | 8.99 | 12.88 | 10.31 | 8.17 | 10.03 | 15.23 | 11.10 | 6.32 | 16.38 | 8.29 | 5.32 | 4.37 | 6.83 | NA | NA | NA | |
Inventory Net | 16.36 | 14.94 | 15.93 | 14.13 | 13.37 | 12.51 | 11.73 | 11.18 | 9.63 | 7.92 | 8.27 | 7.95 | 6.82 | 4.57 | NA | NA | NA | |
Prepaid Expense And Other Assets Current | 3.83 | 4.18 | 3.12 | 3.95 | 5.19 | 4.66 | 3.22 | 3.41 | 3.91 | 4.53 | 2.00 | 2.44 | 2.70 | 0.30 | NA | NA | NA |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Property Plant And Equipment Gross | NA | 9.29 | NA | NA | NA | 7.80 | NA | NA | NA | 5.06 | NA | NA | NA | 5.03 | NA | NA | NA | |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | NA | 5.95 | NA | NA | NA | 4.72 | NA | NA | NA | 3.46 | NA | NA | NA | 4.17 | NA | NA | NA | |
Amortization Of Intangible Assets | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | 0.21 | 0.14 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Property Plant And Equipment Net | 3.21 | 3.34 | 2.85 | 2.94 | 3.04 | 3.08 | 2.76 | 2.42 | 2.18 | 1.60 | 1.59 | 1.61 | 0.97 | 0.85 | NA | NA | NA | |
Goodwill | 10.14 | 10.37 | 9.93 | 10.19 | 10.22 | 10.05 | 9.20 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Intangible Assets Net Excluding Goodwill | 7.47 | 7.86 | 7.74 | 8.16 | 8.41 | 8.49 | 7.97 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Finite Lived Intangible Assets Net | 7.47 | 7.86 | 7.74 | 8.16 | 8.41 | 8.49 | 7.97 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Other Assets Noncurrent | 1.35 | 1.39 | 1.45 | 1.33 | 1.21 | 1.38 | 1.20 | 1.31 | 1.18 | 1.23 | 1.76 | 1.94 | 1.80 | 0.72 | NA | NA | NA |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liabilities Current | 19.33 | 22.55 | 22.32 | 20.19 | 18.66 | 19.23 | 19.08 | 15.43 | 13.66 | 14.84 | 13.06 | 11.18 | 9.25 | 10.83 | NA | NA | NA | |
Accounts Payable Current | 1.47 | 1.19 | 2.58 | 1.49 | 1.74 | 1.40 | 1.66 | 1.23 | 2.16 | 1.37 | 1.99 | 1.00 | 1.69 | 1.00 | NA | NA | NA | |
Other Accrued Liabilities Current | 0.57 | 0.72 | 0.71 | 0.97 | 1.10 | 0.90 | 1.00 | 0.98 | 0.93 | 1.39 | 0.83 | 0.65 | 0.41 | 0.73 | NA | NA | NA | |
Accrued Liabilities Current | 5.30 | 8.71 | 7.27 | 6.03 | 7.23 | 8.85 | 8.56 | 5.96 | 4.35 | 6.96 | 4.93 | 4.94 | 3.01 | 5.04 | NA | NA | NA | |
Contract With Customer Liability Current | 10.48 | 10.63 | 10.52 | 10.81 | 8.00 | 7.51 | 7.42 | 6.84 | 5.78 | 5.16 | 4.84 | 3.96 | 3.32 | 3.10 | NA | NA | NA |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Deferred Income Tax Liabilities Net | 2.32 | 2.44 | 2.41 | 2.58 | 2.67 | 2.67 | 2.57 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Operating Lease Liability Noncurrent | 3.38 | 3.93 | 4.45 | 4.96 | 5.46 | 3.04 | 3.43 | 3.80 | 4.16 | 4.51 | 4.86 | 5.20 | 5.53 | 5.84 | NA | NA | NA |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stockholders Equity | 156.89 | 165.49 | 169.93 | 174.46 | 180.61 | 190.60 | 196.50 | 201.12 | 206.80 | 214.60 | 122.78 | 126.67 | 133.31 | 139.04 | -65.61 | -63.95 | -66.09 | |
Common Stock Value | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | NA | NA | NA | |
Additional Paid In Capital | 337.40 | 334.69 | 332.08 | 329.36 | 326.22 | 323.97 | 321.49 | 319.23 | 316.82 | 315.21 | 219.92 | 218.63 | 217.85 | 217.48 | NA | NA | NA | |
Retained Earnings Accumulated Deficit | -181.52 | -170.60 | -163.17 | -156.08 | -146.73 | -134.20 | -124.41 | -118.15 | -110.05 | -100.64 | -97.17 | -91.99 | -84.56 | -78.47 | NA | NA | NA | |
Accumulated Other Comprehensive Income Loss Net Of Tax | 0.98 | 1.36 | 0.99 | 1.14 | 1.09 | 0.80 | -0.61 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2.64 | NA | 2.70 | 2.58 | 2.17 | NA | 2.02 | 1.89 | 1.29 | NA | 0.81 | 0.48 | 0.34 | NA | 0.08 | 0.07 | 0.07 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -9.36 | -1.93 | -4.60 | -7.88 | -10.65 | -5.12 | -4.94 | -10.41 | -0.47 | -9.22 | -2.92 | -7.30 | -9.63 | 2.33 | 8.20 | -3.23 | -3.17 | |
Net Cash Provided By Used In Investing Activities | -5.78 | 4.64 | -9.91 | -19.94 | -1.19 | -0.61 | -14.51 | -0.07 | -0.62 | -0.05 | -0.06 | -0.62 | -0.01 | 0.00 | 0.17 | -0.09 | -0.09 | |
Net Cash Provided By Used In Financing Activities | -1.29 | 0.10 | -0.25 | -0.40 | -15.38 | 0.41 | 0.17 | 0.47 | 0.13 | 94.53 | 0.48 | 0.28 | -0.57 | 137.18 | 0.01 | 0.00 | 0.00 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -9.36 | -1.93 | -4.60 | -7.88 | -10.65 | -5.12 | -4.94 | -10.41 | -0.47 | -9.22 | -2.92 | -7.30 | -9.63 | 2.33 | 8.20 | -3.23 | -3.17 | |
Net Income Loss | -10.92 | -7.43 | -7.09 | -9.35 | -12.53 | -9.79 | -6.26 | -8.10 | -9.41 | -3.46 | -5.18 | -7.42 | -6.09 | 15.39 | -1.72 | 2.10 | -2.97 | |
Profit Loss | -10.92 | -7.43 | -7.09 | -9.35 | -12.53 | -9.79 | -6.26 | -8.10 | -9.41 | -3.46 | -5.18 | -7.42 | -6.09 | -10.23 | -1.72 | 2.10 | -2.97 | |
Depreciation Depletion And Amortization | 1.33 | 0.41 | 0.74 | 0.60 | 0.63 | 0.58 | 0.46 | 0.31 | 0.27 | 0.29 | 0.26 | 0.24 | 0.14 | 0.22 | 0.20 | 0.20 | 0.20 | |
Increase Decrease In Accounts Receivable | -1.46 | -3.63 | 2.57 | 2.25 | -1.87 | -4.62 | 3.97 | 4.78 | -10.05 | 8.09 | 2.96 | 2.68 | -2.46 | -2.49 | -5.67 | 10.96 | -0.99 | |
Increase Decrease In Inventories | 1.68 | 0.06 | 2.16 | 0.69 | 0.99 | 1.37 | 0.25 | 1.90 | 1.96 | 0.04 | 0.50 | 1.47 | 2.47 | -0.10 | 0.67 | -1.81 | 1.01 | |
Deferred Income Tax Expense Benefit | -0.07 | -0.07 | -0.12 | -0.07 | -0.05 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Share Based Compensation | 2.64 | 2.34 | 2.70 | 2.58 | 2.17 | 2.00 | 2.02 | 1.89 | 1.29 | 0.87 | 0.81 | 0.48 | 0.34 | 0.31 | 0.08 | 0.07 | 0.07 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Investing Activities | -5.78 | 4.64 | -9.91 | -19.94 | -1.19 | -0.61 | -14.51 | -0.07 | -0.62 | -0.05 | -0.06 | -0.62 | -0.01 | 0.00 | 0.17 | -0.09 | -0.09 | |
Payments To Acquire Property Plant And Equipment | 0.90 | 0.33 | 0.21 | 0.32 | 1.19 | 0.61 | 0.74 | 0.07 | 0.62 | 0.05 | 0.06 | 0.62 | 0.01 | 0.00 | -0.17 | 0.09 | 0.09 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Financing Activities | -1.29 | 0.10 | -0.25 | -0.40 | -15.38 | 0.41 | 0.17 | 0.47 | 0.13 | 94.53 | 0.48 | 0.28 | -0.57 | 137.18 | 0.01 | 0.00 | 0.00 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 9.99 | 14.35 | 14.30 | 12.09 | 9.49 | 11.64 | 15.80 | 11.11 | 8.31 | 15.84 | 12.54 | 8.28 | 5.54 | 5.72 | 6.05 | 11.13 | 4.00 | |
Desktop, Device Sales | 0.86 | 1.69 | 1.04 | 1.46 | 1.34 | 1.47 | 2.90 | 2.32 | 2.23 | NA | NA | NA | NA | NA | NA | NA | NA | |
Desktop, Product And Service | 2.57 | 3.22 | 2.55 | 3.13 | 3.09 | 3.29 | 4.42 | 3.67 | 3.56 | 4.27 | 2.93 | 2.64 | 2.12 | 2.79 | 1.70 | 1.55 | 1.10 | |
Desktop, Recurring | 1.71 | 1.53 | 1.51 | 1.67 | 1.75 | 1.82 | 1.52 | 1.35 | 1.33 | NA | NA | NA | NA | NA | NA | NA | NA | |
Handheld, Device Sales | 4.59 | 7.93 | 9.68 | 6.50 | 3.75 | 3.05 | 8.05 | 5.43 | 3.30 | NA | NA | NA | NA | NA | NA | NA | NA | |
Handheld, Product And Service | 7.42 | 11.13 | 11.75 | 8.82 | 6.17 | 7.11 | 11.02 | 6.94 | 4.47 | 11.28 | 9.36 | 5.28 | 3.24 | 3.12 | 4.12 | 8.83 | 1.54 | |
Handheld, Recurring | 2.83 | 3.20 | 2.07 | 2.32 | 2.43 | 4.06 | 2.97 | 1.51 | 1.17 | NA | NA | NA | NA | NA | NA | NA | NA | |
Academia And Other, Product And Service | 0.02 | 0.59 | 0.01 | 0.03 | 0.03 | 0.02 | 0.04 | 0.03 | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Government Authority, Product And Service | 7.43 | 11.13 | 11.74 | 8.81 | 6.18 | 7.18 | 11.07 | 7.00 | 4.72 | 11.74 | 9.51 | 5.28 | 3.23 | 2.91 | 4.06 | 8.97 | 1.45 | |
Pharmaceutical Biotechnology, Product And Service | 2.55 | 2.63 | 2.55 | 3.11 | 3.05 | 3.21 | 4.33 | 3.58 | 3.13 | 3.79 | 2.77 | 2.61 | 2.10 | 3.00 | 1.75 | 1.17 | 1.18 | |
Contract | NA | 0.00 | 0.00 | 0.14 | 0.23 | 1.24 | 0.36 | 0.50 | 0.28 | NA | NA | NA | NA | NA | NA | NA | NA | |
Device Sales | 5.45 | 9.62 | 10.72 | 7.96 | 5.08 | 4.52 | 10.95 | 7.75 | 5.53 | NA | NA | NA | NA | NA | NA | NA | NA | |
Product And Service | 9.99 | 14.35 | 14.30 | 11.95 | 9.26 | 10.40 | 15.44 | 10.61 | 8.03 | 15.55 | 12.29 | 7.92 | 5.36 | 5.91 | 5.83 | 10.38 | 2.64 | |
Recurring | 4.54 | 4.73 | 3.58 | 3.99 | 4.18 | 5.88 | 4.49 | 2.85 | 2.50 | NA | NA | NA | NA | NA | NA | NA | NA | |
Product | 7.23 | 11.44 | 12.16 | 9.60 | 7.02 | 4.52 | 10.95 | 7.75 | 5.53 | 13.12 | 10.07 | 6.18 | 3.91 | 4.50 | 4.88 | 10.25 | 1.99 | |
Service | 2.76 | 2.92 | 2.14 | 2.35 | 2.24 | 5.88 | 4.49 | 2.85 | 2.50 | 2.43 | 2.21 | 1.73 | 1.45 | 1.41 | 0.94 | 0.13 | 0.65 | |
0.37 | 0.63 | 0.39 | 0.22 | 0.58 | 0.62 | 1.00 | 0.39 | 0.88 | 0.45 | 0.64 | 0.74 | 0.42 | 0.43 | 0.26 | 1.00 | 0.20 | ||
US | 7.27 | 11.40 | 12.42 | 7.86 | 6.49 | 9.68 | 12.40 | 9.46 | 6.05 | NA | NA | NA | NA | NA | NA | NA | NA | |
Americas Other | 0.29 | 0.33 | 0.03 | 0.06 | 0.43 | 0.01 | 0.04 | 0.01 | 0.01 | NA | NA | NA | NA | NA | NA | NA | NA | |
EMEA | 2.06 | 1.98 | 1.46 | 3.95 | 1.99 | 1.33 | 2.36 | 1.25 | 1.36 | 1.45 | 0.84 | 1.73 | 0.45 | 1.25 | 0.72 | 0.45 | 0.42 | |
Revenue From Contract With Customer Excluding Assessed Tax | 9.99 | 14.35 | 14.30 | 12.09 | 9.49 | 11.64 | 15.80 | 11.11 | 8.31 | 15.84 | 12.54 | 8.28 | 5.54 | 5.72 | 6.05 | 11.13 | 4.00 | |
Desktop, Device Sales | 0.86 | 1.69 | 1.04 | 1.46 | 1.34 | 1.47 | 2.90 | 2.32 | 2.23 | NA | NA | NA | NA | NA | NA | NA | NA | |
Desktop, Product And Service | 2.57 | 3.22 | 2.55 | 3.13 | 3.09 | 3.29 | 4.42 | 3.67 | 3.56 | 4.27 | 2.93 | 2.64 | 2.12 | 2.79 | 1.70 | 1.55 | 1.10 | |
Desktop, Recurring | 1.71 | 1.53 | 1.51 | 1.67 | 1.75 | 1.82 | 1.52 | 1.35 | 1.33 | NA | NA | NA | NA | NA | NA | NA | NA | |
Handheld, Device Sales | 4.59 | 7.93 | 9.68 | 6.50 | 3.75 | 3.05 | 8.05 | 5.43 | 3.30 | NA | NA | NA | NA | NA | NA | NA | NA | |
Handheld, Product And Service | 7.42 | 11.13 | 11.75 | 8.82 | 6.17 | 7.11 | 11.02 | 6.94 | 4.47 | 11.28 | 9.36 | 5.28 | 3.24 | 3.12 | 4.12 | 8.83 | 1.54 | |
Handheld, Recurring | 2.83 | 3.20 | 2.07 | 2.32 | 2.43 | 4.06 | 2.97 | 1.51 | 1.17 | NA | NA | NA | NA | NA | NA | NA | NA | |
Academia And Other, Product And Service | 0.02 | 0.59 | 0.01 | 0.03 | 0.03 | 0.02 | 0.04 | 0.03 | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Government Authority, Product And Service | 7.43 | 11.13 | 11.74 | 8.81 | 6.18 | 7.18 | 11.07 | 7.00 | 4.72 | 11.74 | 9.51 | 5.28 | 3.23 | 2.91 | 4.06 | 8.97 | 1.45 | |
Pharmaceutical Biotechnology, Product And Service | 2.55 | 2.63 | 2.55 | 3.11 | 3.05 | 3.21 | 4.33 | 3.58 | 3.13 | 3.79 | 2.77 | 2.61 | 2.10 | 3.00 | 1.75 | 1.17 | 1.18 | |
Contract | NA | 0.00 | 0.00 | 0.14 | 0.23 | 1.24 | 0.36 | 0.50 | 0.28 | NA | NA | NA | NA | NA | NA | NA | NA | |
Device Sales | 5.45 | 9.62 | 10.72 | 7.96 | 5.08 | 4.52 | 10.95 | 7.75 | 5.53 | NA | NA | NA | NA | NA | NA | NA | NA | |
Product And Service | 9.99 | 14.35 | 14.30 | 11.95 | 9.26 | 10.40 | 15.44 | 10.61 | 8.03 | 15.55 | 12.29 | 7.92 | 5.36 | 5.91 | 5.83 | 10.38 | 2.64 | |
Recurring | 4.54 | 4.73 | 3.58 | 3.99 | 4.18 | 5.88 | 4.49 | 2.85 | 2.50 | NA | NA | NA | NA | NA | NA | NA | NA | |
Product | 7.23 | 11.44 | 12.16 | 9.60 | 7.02 | 4.52 | 10.95 | 7.75 | 5.53 | 13.12 | 10.07 | 6.18 | 3.91 | 4.50 | 4.88 | 10.25 | 1.99 | |
Service | 2.76 | 2.92 | 2.14 | 2.35 | 2.24 | 5.88 | 4.49 | 2.85 | 2.50 | 2.43 | 2.21 | 1.73 | 1.45 | 1.41 | 0.94 | 0.13 | 0.65 | |
0.37 | 0.63 | 0.39 | 0.22 | 0.58 | 0.62 | 1.00 | 0.39 | 0.88 | 0.45 | 0.64 | 0.74 | 0.42 | 0.43 | 0.26 | 1.00 | 0.20 | ||
US | 7.27 | 11.40 | 12.42 | 7.86 | 6.49 | 9.68 | 12.40 | 9.46 | 6.05 | NA | NA | NA | NA | NA | NA | NA | NA | |
Americas Other | 0.29 | 0.33 | 0.03 | 0.06 | 0.43 | 0.01 | 0.04 | 0.01 | 0.01 | NA | NA | NA | NA | NA | NA | NA | NA | |
EMEA | 2.06 | 1.98 | 1.46 | 3.95 | 1.99 | 1.33 | 2.36 | 1.25 | 1.36 | 1.45 | 0.84 | 1.73 | 0.45 | 1.25 | 0.72 | 0.45 | 0.42 |